Cardio-renal-metabolic multimorbidity

There are 27 papers on cardio-renal-metabolic multimorbidity in aging research: 27 observational studies in people. The newest story, Oct 4, 2026: “Metabolic markers jointly link to higher multimorbidity risk”.

Disease

27 papers study it3 more mention it45 findings

2 new papers in 30 daysSee all 30 papers on cardio-renal-metabolic multimorbidity

At a glance

Frailty and higher PhenoAge are linked with higher cardio-renal-metabolic multimorbidity risk in human cohorts. Higher glucose, insulin-resistance indices, triglycerides, LDL cholesterol and ultra-processed food intake are also linked with higher risk, while physical activity is linked with less progression after a first cardio-renal-metabolic disease. Serum insulin shows no clear link.

45 findings in 21 papers from 2025 to 2026, 15 of them since April 2026

“Moving from LE4-low to LE4-high attenuated the risks of CRMM associated with progressive or persistent obesity trajectories by 26.8-37.8%.”
Life-course body size trajectories and the progression of cardio-renal-metabolic multimorbidity: a prospective UK biobank studyNutrition & metabolism2026doi:10.1186/s12986-026-01148-7
  • Humans27

Interventions

1

Serum insulin

no changein humans1HR 1.1

1 study
  1. Serum insulin was not clearly linked with cardio-renal-metabolic multimorbidity in humans (per 1-standard deviation increase in natural log) (HR 1.10 (95% CI 0.91-1.32) per 1-SD increase in natural log).

    “Hazard ratios (HRs) of incident CRMM associated with each 1-standard deviation (SD) increase in FPG, 2hPG, insulin (natural log), and HOMA-IR (natural log) were 1.48 (95 % CI: 1.34-1.64)”

    Humansper 1-standard deviation increase in natural logmedian follow-up of 15.3 years

    Nonlinear association between glycemic markers and incident cardio‑renal‑metabolic multimorbidity: two decades of follow‑up in the Tehran Lipid and Glucose Study

    American journal of preventive cardiology

More on Serum insulin

Upstream

2

C-reactive protein-triglyceride-glucose index

mediatesin humans1

1 study
  1. C-reactive protein-triglyceride-glucose index is linked with cardio-renal-metabolic multimorbidity in humans (sustained or progressive obesity trajectories) (approximately 42-54% of the associations).

    “CTI mediated approximately 42-54% of the associations between sustained or progressive obesity trajectories and CRMM comorbidity outcomes.”

    Humanssustained or progressive obesity trajectories

    Life-course body size trajectories and the progression of cardio-renal-metabolic multimorbidity: a prospective UK biobank study

    Nutrition & metabolism

More on C-reactive protein-triglyceride-glucose index

Kidney function

mediatesin humans1

1 study
  1. Kidney function is linked with cardio-renal-metabolic multimorbidity in humans.

    “Mediation analyses indicated that systemic inflammation, organ function, and especially kidney function partially mediated the observed associations.”

    Humanspartial mediation of associations between insulin resistance-related indices and CRM multimorbidity

    Associations of six insulin resistance-related indices with the risk and progression of cardio-renal-metabolic multimorbidity: evidence from the UK biobank

    Cardiovascular diabetology

More on Kidney function

Associations

39

Ultra-processed foods

upin humans2HR 1.16–1.79

2 studies
  1. Ultra-processed foods are linked with a higher risk of cardio-renal-metabolic multimorbidity in humans (HR 1.79, 95% CI 1.12-2.86).

    “Participants in the highest quartile of UPF consumption had a significantly increased risk of CRMM compared with the lowest quartile”

    Humansgrams per daymedian 11.6 yearsn = 2,539

    The association between ultra-processed food consumption and incidence of cardio-renal-metabolic multimorbidity: Tehran Lipid and Glucose Study

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  2. Ultra-processed foods are linked with a higher risk of cardio-renal-metabolic multimorbidity in humans (HR: 1.16; 95% CI: 1.14-1.19).

    “An interquartile range increase in UPF intake was linked to higher risks of developing a first CRM disease (HR: 1.16; 95% CI: 1.14-1.19)”

    Humans13.7 yearsn = 115,745

    Ultra-processed food consumption and the trajectory of cardio-renal-metabolic multimorbidity: insights from multi-state modelling

    Food & function

More on Ultra-processed foods

Frailty index

upin humans1

1 study
  1. Frailty index is associated with cardio-renal-metabolic multimorbidity in humans.

    “Significant positive additive interactions were observed between FI and TyG, TyG-BMI, TyG-BRI, TyG-WHtR, TyG-cVAI, and METS-IR.”

    Humans2011-2020n = 6,502

    Comparative predictive value of the frailty index combined with non-insulin-based insulin resistance indicators for cardio-renal-metabolic multimorbidity risk: a large nationwide prospective cohort study

    Journal of diabetes and metabolic disorders

  2. Frailty index is linked with a higher risk of cardio-renal-metabolic multimorbidity in humans.

    “the FI-Z-score and all FI-integrated non-insulin-based insulin resistance indices were positively associated with CRMM risk”

    Humans2011-2020n = 6,502

    Comparative predictive value of the frailty index combined with non-insulin-based insulin resistance indicators for cardio-renal-metabolic multimorbidity risk: a large nationwide prospective cohort study

    Journal of diabetes and metabolic disorders

More on Frailty index

MetaboHealth score

upin humans1HR 1.503

1 study
  1. MetaboHealth score is associated with cardio-renal-metabolic multimorbidity in humans (cross-sectional, fully adjusted).

    “In cross-sectional analyses, the MetaboHealth score, but not MVX, was associated with prevalent CRM multimorbidity after full adjustment.”

    Humanscross-sectional, fully adjustedn = 269,530

    MetaboHealth and Metabolic Vulnerability Index as Risk Factors for Cardio-Renal-Metabolic Multimorbidity: A Large-Scale Prospective Cohort Study

    Diabetes, obesity & metabolism

  2. MetaboHealth score is linked with a higher risk of cardio-renal-metabolic multimorbidity in humans (fully adjusted Cox models) (HR 1.503 (95% CI 1.469-1.538, p < 0.001)).

    “1.503 (95% CI 1.469-1.538, p < 0.001), respectively.”

    Humansfully adjusted Cox modelseach 1-SD increment10-yearn = 240,576

    MetaboHealth and Metabolic Vulnerability Index as Risk Factors for Cardio-Renal-Metabolic Multimorbidity: A Large-Scale Prospective Cohort Study

    Diabetes, obesity & metabolism

More on MetaboHealth score

Alternative healthy eating INDEX-2010

downin humans1HR 0.49

1 study
  1. Alternative healthy eating INDEX-2010 is associated with cardio-renal-metabolic multimorbidity in humans (Initially free of cardio-renal-metabolic multimorbidity; multivariable-adjusted analysis) (51% lower risk; HR 0.49, 95% CI 0.35–0.70; P for trend = 0.007).

    “Greater adherence to the DASH and AHEI-2010 diet quality indices may be inversely associated with risk of CRMM.”

    HumansInitially free of cardio-renal-metabolic multimorbidity; multivariable-adjusted analysisHighest versus lowest tertile of AHEI-2010 scoreMedian follow-up of 11.6 yearsn = 2,539

    The association between diet quality indices and risk of cardio-renal-metabolic multimorbidity: a decade follow-up of the Tehran Lipid and Glucose Study

    Diabetology & metabolic syndrome

More on Alternative healthy eating INDEX-2010

Dash diet

downin humans1HR 0.62

1 study
  1. Dash diet is associated with cardio-renal-metabolic multimorbidity in humans (Initially free of cardio-renal-metabolic multimorbidity; multivariable-adjusted analysis) (38% lower risk; HR 0.62, 95% CI 0.42–0.90; P for trend = 0.038).

    “Greater adherence to the DASH and AHEI-2010 diet quality indices may be inversely associated with risk of CRMM.”

    HumansInitially free of cardio-renal-metabolic multimorbidity; multivariable-adjusted analysisHighest versus lowest tertile of DASH scoreMedian follow-up of 11.6 yearsn = 2,539

    The association between diet quality indices and risk of cardio-renal-metabolic multimorbidity: a decade follow-up of the Tehran Lipid and Glucose Study

    Diabetology & metabolic syndrome

More on Dash diet

Atherogenic index of plasma

upin humans1HR 2.31

1 study
  1. Atherogenic index of plasma is linked with a higher risk of cardio-renal-metabolic multimorbidity in humans (HR 2.31).

    “In UK Biobank, high AIP and low eGDR were each associated with higher CRMM risk (fully adjusted HRs, 2.31 and 2.54, respectively).”

    Humans

    Metabolic markers jointly link to higher multimorbidity risk

    Research SquarePreprint

More on Atherogenic index of plasma

CTI-WHtR

upin humans1HR 1.919

1 study
  1. CTI-WHtR is linked with a higher risk of cardio-renal-metabolic multimorbidity in UK Biobank (HR 1.919, 95% CI 1.890-1.950).

    “followed by CTI-WHtR (HR 1.919, 95% CI 1.890-1.950).”

    Humansin UK Biobank15.98 yearsn = 374,513

    The C-reactive protein-triglyceride-glucose index and its obesity-derived indicators predict cardio-renal-metabolic multimorbidity: evidence from the UK biobank and CHARLS

    Diabetes research and clinical practice

More on CTI-WHtR

CTI-WC

upin humans1HR 1.974

1 study
  1. CTI-WC is linked with a higher risk of cardio-renal-metabolic multimorbidity in UK Biobank (HR 1.974, 95% CI 1.943-2.007).

    “CTI-WC showing the strongest association (HR 1.974, 95% CI 1.943-2.007), followed by CTI-WHtR (HR 1.919, 95% CI 1.890-1.950).”

    Humansin UK Biobank15.98 yearsn = 374,513

    The C-reactive protein-triglyceride-glucose index and its obesity-derived indicators predict cardio-renal-metabolic multimorbidity: evidence from the UK biobank and CHARLS

    Diabetes research and clinical practice

More on CTI-WC

Sleep duration

upin humans1OR 2.3

1 study
  1. Sleep duration is associated with cardio-renal-metabolic multimorbidity in humans (Postmenopausal women; compared with the normal-stable sleep duration trajectory) (OR 2.30, 95% CI 1.35–3.91).

    “Compared with normal-stable group, those in normal-fluctuating decline and short-rapid decline groups had an increased risk of CRMM”

    HumansPostmenopausal women; compared with the normal-stable sleep duration trajectorynormal-fluctuating declinemedian follow-up of 2 yearsfemalesn = 2,859

    Longitudinal sleep duration trajectories and their association with cardio-renal-metabolic multimorbidity risk in postmenopausal women: evidence from the CHARLS study

    BMC public health

More on Sleep duration

Metabolic vulnerability index

upin humans1HR 1.213

1 study
  1. Metabolic vulnerability index is linked with a higher risk of cardio-renal-metabolic multimorbidity in humans (fully adjusted Cox models) (HR 1.213 (95% CI 1.186-1.241, p < 0.001)).

    “each 1-SD increment in MVX and the MetaboHealth score was associated with a higher risk of incident CRM multimorbidity, with HRs of 1.213 (95% CI 1.186-1.241, p < 0.001)”

    Humansfully adjusted Cox modelseach 1-SD increment10-yearn = 240,576

    MetaboHealth and Metabolic Vulnerability Index as Risk Factors for Cardio-Renal-Metabolic Multimorbidity: A Large-Scale Prospective Cohort Study

    Diabetes, obesity & metabolism

More on Metabolic vulnerability index

All 39

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 1Apr 2026: 2May 2026: 5Jun 2026: 4Jul 2026: 4Aug 2026: 2Sep 2026: 2Oct 2026: 2Nov 2026: 124 papers in 12 months
Diabetes, Obesity & Metabolism

Cardiometabolic markers track the progression of multiple diseases

Compared with the lowest risk category, the highest was associated with hazard ratios of 2.80, 1.84 and 1.71 for developing one, two and three conditions.Compared with the lowest risk category, the highest was associated with hazard ratios of 2.80, 1.84 and 1.71 for developing one, two and three conditions.

Cohort · 262,464 peopleBiomarkers
Research Square

Metabolic markers jointly link to higher multimorbidity risk

In the UK Biobank, participants with high AIP and low eGDR had a hazard ratio of 5.24 for multimorbidity compared with the low-AIP and high-eGDR group.In the UK Biobank, participants with high AIP and low eGDR had a hazard ratio of 5.24 for multimorbidity compared with the low-AIP and high-eGDR group.

Preprint: cohort study of 394,483 peopleBiomarkers

See all 30 papers on cardio-renal-metabolic multimorbidity